论文信息 - Abstract 1701: EPL-1410, a novel fused heterocycle based orally active dual inhibitor of IDO1/TDO2, as a potential immune-oncology therapeutic - 字舞流文

Abstract 1701: EPL-1410, a novel fused heterocycle based orally active dual inhibitor of IDO1/TDO2, as a potential immune-oncology therapeutic

P. Singh | S. Gullapalli | M. K. Gurjar | Jayanarayan Kulathingal | Abhijit Roychowdhury | R. Janrao | R. R. Lekkala | T. Khaladkar | Sangameshaver Sawargave | V. Kalhapure | Ganesh Urunkar | Sonali Bhadra | Krishna Anand Putta | Sonali Manwatkar | Prashant Surve